P1361: TREATMENT OF SEVERE STEROID-REFRACTORY ACUTE GVHD WITH MESENCHYMAL STROMAL CELLS: RESULTS OF THE PHASE III RANDOMIZED DOUBLE-BLIND MULTI-CENTER HOVON-113 TRIAL

Bibliographic Details
Main Authors: L. Oosten, M. van Pel, B. van der Holt, E. Bach, M. Cross, H. Roelofs, P. Meij, B. Wieles, J. J. Zwaginga, A. Lankester, H. Veelken, U. Platzbecker, F. Sanchez-Guijo, M. Algeri, F. Locatelli, T. Devos, J. Cornelissen, D. Niederwieser, W. Fibbe
Format: Article
Language:English
Published: Wiley 2022-06-01
Series:HemaSphere
Online Access:http://journals.lww.com/10.1097/01.HS9.0000848304.76865.3a
_version_ 1797287236145774592
author L. Oosten
M. van Pel
B. van der Holt
E. Bach
M. Cross
H. Roelofs
P. Meij
B. Wieles
J. J. Zwaginga
A. Lankester
H. Veelken
U. Platzbecker
F. Sanchez-Guijo
M. Algeri
F. Locatelli
T. Devos
J. Cornelissen
D. Niederwieser
W. Fibbe
author_facet L. Oosten
M. van Pel
B. van der Holt
E. Bach
M. Cross
H. Roelofs
P. Meij
B. Wieles
J. J. Zwaginga
A. Lankester
H. Veelken
U. Platzbecker
F. Sanchez-Guijo
M. Algeri
F. Locatelli
T. Devos
J. Cornelissen
D. Niederwieser
W. Fibbe
author_sort L. Oosten
collection DOAJ
first_indexed 2024-03-07T18:30:02Z
format Article
id doaj.art-7b7fa12d174e4f76a81f3068ba286e4d
institution Directory Open Access Journal
issn 2572-9241
language English
last_indexed 2024-03-07T18:30:02Z
publishDate 2022-06-01
publisher Wiley
record_format Article
series HemaSphere
spelling doaj.art-7b7fa12d174e4f76a81f3068ba286e4d2024-03-02T06:40:29ZengWileyHemaSphere2572-92412022-06-0161245124610.1097/01.HS9.0000848304.76865.3a202206003-01245P1361: TREATMENT OF SEVERE STEROID-REFRACTORY ACUTE GVHD WITH MESENCHYMAL STROMAL CELLS: RESULTS OF THE PHASE III RANDOMIZED DOUBLE-BLIND MULTI-CENTER HOVON-113 TRIALL. Oosten0M. van Pel1B. van der Holt2E. Bach3M. Cross4H. Roelofs5P. Meij6B. Wieles7J. J. Zwaginga8A. Lankester9H. Veelken10U. Platzbecker11F. Sanchez-Guijo12M. Algeri13F. Locatelli14T. Devos15J. Cornelissen16D. Niederwieser17W. Fibbe181 Hematology2 Nephrology, Leiden University Medical Center, Leiden3 HOVON Data Center, Hematology, Erasmus MC Cancer Institute, Rotterdam, Netherlands4 Medical Clinic and Policlinic 1, Hematology and Cellular Therapy, University Hospital Leipzig, Leipzig, Germany4 Medical Clinic and Policlinic 1, Hematology and Cellular Therapy, University Hospital Leipzig, Leipzig, Germany5 Clinical Pharmacy and Toxicology5 Clinical Pharmacy and Toxicology2 Nephrology, Leiden University Medical Center, Leiden1 Hematology6 Pediatrics, Leiden University Medical Center, Leiden, Netherlands1 Hematology4 Medical Clinic and Policlinic 1, Hematology and Cellular Therapy, University Hospital Leipzig, Leipzig, Germany7 Hematology, IBSAL-Hospital Universitario de Salamanca, CIC and CIBERONC, University of Salamanca, Salamanca, Spain8 Pediatric Hematology and Oncology, Cellular and Gene Therapy, Bambino Gesù Children’s Hospital, Sapienza, University of Rome, Rome, Italy8 Pediatric Hematology and Oncology, Cellular and Gene Therapy, Bambino Gesù Children’s Hospital, Sapienza, University of Rome, Rome, Italy9 Hematology, University Hospitals Leuven and Department of Microbiology and Immunology, Laboratory of Molecular Immunology (Rega Institute), KU Leuven, Leuven, Belgium10 Hematology, Erasmus MC Cancer Institute, Rotterdam, Netherlands4 Medical Clinic and Policlinic 1, Hematology and Cellular Therapy, University Hospital Leipzig, Leipzig, Germany2 Nephrology, Leiden University Medical Center, Leidenhttp://journals.lww.com/10.1097/01.HS9.0000848304.76865.3a
spellingShingle L. Oosten
M. van Pel
B. van der Holt
E. Bach
M. Cross
H. Roelofs
P. Meij
B. Wieles
J. J. Zwaginga
A. Lankester
H. Veelken
U. Platzbecker
F. Sanchez-Guijo
M. Algeri
F. Locatelli
T. Devos
J. Cornelissen
D. Niederwieser
W. Fibbe
P1361: TREATMENT OF SEVERE STEROID-REFRACTORY ACUTE GVHD WITH MESENCHYMAL STROMAL CELLS: RESULTS OF THE PHASE III RANDOMIZED DOUBLE-BLIND MULTI-CENTER HOVON-113 TRIAL
HemaSphere
title P1361: TREATMENT OF SEVERE STEROID-REFRACTORY ACUTE GVHD WITH MESENCHYMAL STROMAL CELLS: RESULTS OF THE PHASE III RANDOMIZED DOUBLE-BLIND MULTI-CENTER HOVON-113 TRIAL
title_full P1361: TREATMENT OF SEVERE STEROID-REFRACTORY ACUTE GVHD WITH MESENCHYMAL STROMAL CELLS: RESULTS OF THE PHASE III RANDOMIZED DOUBLE-BLIND MULTI-CENTER HOVON-113 TRIAL
title_fullStr P1361: TREATMENT OF SEVERE STEROID-REFRACTORY ACUTE GVHD WITH MESENCHYMAL STROMAL CELLS: RESULTS OF THE PHASE III RANDOMIZED DOUBLE-BLIND MULTI-CENTER HOVON-113 TRIAL
title_full_unstemmed P1361: TREATMENT OF SEVERE STEROID-REFRACTORY ACUTE GVHD WITH MESENCHYMAL STROMAL CELLS: RESULTS OF THE PHASE III RANDOMIZED DOUBLE-BLIND MULTI-CENTER HOVON-113 TRIAL
title_short P1361: TREATMENT OF SEVERE STEROID-REFRACTORY ACUTE GVHD WITH MESENCHYMAL STROMAL CELLS: RESULTS OF THE PHASE III RANDOMIZED DOUBLE-BLIND MULTI-CENTER HOVON-113 TRIAL
title_sort p1361 treatment of severe steroid refractory acute gvhd with mesenchymal stromal cells results of the phase iii randomized double blind multi center hovon 113 trial
url http://journals.lww.com/10.1097/01.HS9.0000848304.76865.3a
work_keys_str_mv AT loosten p1361treatmentofseveresteroidrefractoryacutegvhdwithmesenchymalstromalcellsresultsofthephaseiiirandomizeddoubleblindmulticenterhovon113trial
AT mvanpel p1361treatmentofseveresteroidrefractoryacutegvhdwithmesenchymalstromalcellsresultsofthephaseiiirandomizeddoubleblindmulticenterhovon113trial
AT bvanderholt p1361treatmentofseveresteroidrefractoryacutegvhdwithmesenchymalstromalcellsresultsofthephaseiiirandomizeddoubleblindmulticenterhovon113trial
AT ebach p1361treatmentofseveresteroidrefractoryacutegvhdwithmesenchymalstromalcellsresultsofthephaseiiirandomizeddoubleblindmulticenterhovon113trial
AT mcross p1361treatmentofseveresteroidrefractoryacutegvhdwithmesenchymalstromalcellsresultsofthephaseiiirandomizeddoubleblindmulticenterhovon113trial
AT hroelofs p1361treatmentofseveresteroidrefractoryacutegvhdwithmesenchymalstromalcellsresultsofthephaseiiirandomizeddoubleblindmulticenterhovon113trial
AT pmeij p1361treatmentofseveresteroidrefractoryacutegvhdwithmesenchymalstromalcellsresultsofthephaseiiirandomizeddoubleblindmulticenterhovon113trial
AT bwieles p1361treatmentofseveresteroidrefractoryacutegvhdwithmesenchymalstromalcellsresultsofthephaseiiirandomizeddoubleblindmulticenterhovon113trial
AT jjzwaginga p1361treatmentofseveresteroidrefractoryacutegvhdwithmesenchymalstromalcellsresultsofthephaseiiirandomizeddoubleblindmulticenterhovon113trial
AT alankester p1361treatmentofseveresteroidrefractoryacutegvhdwithmesenchymalstromalcellsresultsofthephaseiiirandomizeddoubleblindmulticenterhovon113trial
AT hveelken p1361treatmentofseveresteroidrefractoryacutegvhdwithmesenchymalstromalcellsresultsofthephaseiiirandomizeddoubleblindmulticenterhovon113trial
AT uplatzbecker p1361treatmentofseveresteroidrefractoryacutegvhdwithmesenchymalstromalcellsresultsofthephaseiiirandomizeddoubleblindmulticenterhovon113trial
AT fsanchezguijo p1361treatmentofseveresteroidrefractoryacutegvhdwithmesenchymalstromalcellsresultsofthephaseiiirandomizeddoubleblindmulticenterhovon113trial
AT malgeri p1361treatmentofseveresteroidrefractoryacutegvhdwithmesenchymalstromalcellsresultsofthephaseiiirandomizeddoubleblindmulticenterhovon113trial
AT flocatelli p1361treatmentofseveresteroidrefractoryacutegvhdwithmesenchymalstromalcellsresultsofthephaseiiirandomizeddoubleblindmulticenterhovon113trial
AT tdevos p1361treatmentofseveresteroidrefractoryacutegvhdwithmesenchymalstromalcellsresultsofthephaseiiirandomizeddoubleblindmulticenterhovon113trial
AT jcornelissen p1361treatmentofseveresteroidrefractoryacutegvhdwithmesenchymalstromalcellsresultsofthephaseiiirandomizeddoubleblindmulticenterhovon113trial
AT dniederwieser p1361treatmentofseveresteroidrefractoryacutegvhdwithmesenchymalstromalcellsresultsofthephaseiiirandomizeddoubleblindmulticenterhovon113trial
AT wfibbe p1361treatmentofseveresteroidrefractoryacutegvhdwithmesenchymalstromalcellsresultsofthephaseiiirandomizeddoubleblindmulticenterhovon113trial